strong	O
interference	O
of	O
hemoglobin	O
concentration	O
on	O
csf	O
total	O
protein	O
measurement	O
using	O
the	O
trichloroacetic	B
acid	I
precipitation	O
method	O
..	O
background	O
:	O
among	O
other	O
methods	O
,	O
trichloroacetic	B
acid	I
precipitation	O
is	O
used	O
to	O
quantify	O
total	O
protein	O
in	O
cerebrospinal	O
fluid	O
(	O
csf	O
)	O
.	O

methods	O
:	O
we	O
analyzed	O
the	O
influence	O
of	O
hemoglobin	O
on	O
total	O
protein	O
concentration	O
assayed	O
by	O
the	O
trichloroacetic	B
acid	I
method	O
and	O
compared	O
the	O
results	O
to	O
the	O
benzethonium	O
chloride	O
method	O
.	O

results	O
:	O
four	O
csf	O
samples	O
were	O
spiked	O
with	O
different	O
amounts	O
of	O
hemoglobin	O
,	O
leading	O
to	O
overestimation	O
of	O
protein	O
concentration	O
when	O
assayed	O
by	O
the	O
trichloroacetic	B
acid	I
method	O
.	O
using	O
the	O
benzethonium	O
chloride	O
method	O
,	O
measurement	O
of	O
protein	O
concentration	O
was	O
minimally	O
disturbed	O
.	O

the	O
total	O
protein	O
/	O
albumin	O
ratio	O
remained	O
constant	O
when	O
protein	O
was	O
measured	O
with	O
the	O
benzethonium	O
chloride	O
method	O
,	O
while	O
ratios	O
increased	O
when	O
protein	O
was	O
assayed	O
by	O
the	O
trichloroacetic	B
acid	I
method	O
.	O

conclusions	O
:	O
strong	O
interference	O
by	O
hemoglobin	O
leads	O
to	O
overestimation	O
of	O
the	O
total	O
protein	O
concentration	O
in	O
csf	O
when	O
assayed	O
by	O
the	O
trichloroacetic	B
acid	I
method	O
and	O
may	O
lead	O
to	O
false	O
conclusions	O
when	O
evaluating	O
the	O
blood	O
-	O
brain	O
barrier	O
.	O

the	O
disinfection	O
by	O
-	O
product	O
(	O
dbp	O
)	O
dichloroacetic	B
acid	I
is	O
a	O
hepatocarcinogen	O
in	O
fischer	O
344	O
rats	O
and	O
b6c3f1	O
mice	O
.	O

to	O
examine	O
this	O
,	O
we	O
exposed	O
salmonella	O
rsj100	O
and	O
a	O
control	O
strain	O
not	O
expressing	O
the	O
gene	O
(	O
tpt100	O
)	O
to	O
the	O
most	O
mutagenic	O
brominated	O
thm	O
detected	O
in	O
salmonella	O
,	O
dibromochloromethane	B
(	O
dbcm	O
)	O
,	O
either	O
in	O
the	O
presence	O
or	O
absence	O
of	O
s9	O
or	O
red	O
blood	O
cells	O
from	O
gstt1	O
-	O
1(+	O
)	O
or	O
gstt1	O
-	O
1(-	O
)	O
individuals	O
.	O

blood	O
:	O
air	O
partition	O
coefficients	O
of	O
individual	O
and	O
mixtures	O
of	O
trihalomethanes	O
..	O
the	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
determine	O
the	O
rat	O
blood	O
:	O
air	O
partition	O
coefficients	O
(	O
p(b	O
:	O
a	O
)	O
)	O
of	O
chloroform	O
,	O
bromodichloromethane	O
,	O
dibromochloromethane	B
and	O
bromoform	O
present	O
in	O
vitro	O
individually	O
or	O
as	O
mixtures	O
.	O

the	O
experimentally	O
determined	O
p(b	O
:	O
a	O
)	O
of	O
chloroform	O
,	O
bromodichloromethane	O
,	O
dibromochloromethane	B
and	O
bromoform	O
present	O
individually	O
corresponded	O
to	O
(	O
mean	O
+	O
/-	O
sd	O
,	O
n	O
=	O
8)	O
21.3	O
+	O
/-	O
1.8	O
,	O
41.8	O
+	O
/-	O
6.2	O
,	O
97.5	O
+	O
/-	O
4.1	O
,	O
and	O
187	O
+	O
/-	O
7.4	O
,	O
respectively	O
.	O

development	O
of	O
a	O
trichloroacetic	B
acid	I
precipitation	O
assay	O
for	O
covalent	O
adducts	O
of	O
thymidylate	O
synthase	O
..	O
the	O
use	O
of	O
trichloroacetic	B
acid	I
as	O
a	O
protein	O
precipitant	O
and	O
denaturant	O
in	O
the	O
quantitative	O
measurement	O
of	O
covalent	O
complexes	O
of	O
thymidylate	O
synthase	O
is	O
described	O
.	O

enzyme	O
inactivated	O
with	O
n[3h]ethylmaleimide	O
and	O
inhibitory	O
ternary	O
complex	O
(	O
formed	O
with	O
native	O
enzyme	O
,	O
5-[6	O
-	O
3h]fluoro-2'-deoxyuridylate	O
,	O
and	O
methylenetetrahydrofolate	O
)	O
served	O
as	O
reagents	O
which	O
were	O
used	O
to	O
establish	O
the	O
conditions	O
under	O
which	O
trichloroacetic	B
acid	I
precipitation	O
,	O
washing	O
,	O
and	O
solubilization	O
steps	O
provided	O
quantitative	O
results	O
.	O

the	O
ternary	O
complex	O
formed	O
by	O
dihydrofolate	O
reductase	O
with	O
[	O
3h]methotrexate	O
and	O
nadph	O
was	O
used	O
as	O
a	O
control	O
to	O
assess	O
whether	O
tight	O
,	O
but	O
noncovalent	O
,	O
enzyme	O
:	O
ligand	O
complexes	O
survived	O
trichloroacetic	B
acid	I
precipitation	O
.	O

the	O
ability	O
of	O
the	O
enzyme	O
to	O
bind	O
5-[6	O
-	O
3h]fluoro-2'-deoxyuridylate	O
specifically	O
,	O
as	O
measured	O
by	O
the	O
trichloroacetic	B
acid	I
assay	O
,	O
generated	O
a	O
specific	O
binding	O
value	O
of	O
13.4	O
nmol	O
of	O
enzyme	O
/	O
mg	O
protein	O
(	O
assuming	O
a	O
binding	O
ratio	O
of	O
1.5	O
for	O
the	O
inhibitory	O
ternary	O
complex	O
)	O
.	O

tandem	O
mass	O
spectrometry	O
study	O
of	O
c	O
-	O
phenyl	O
-	O
n	O
-	O
tert	O
-	O
butyl	O
nitrone	O
spin	O
adducts	O
from	O
in	O
vitro	O
rat	O
liver	O
microsomal	O
metabolism	O
of	O
bromotrichloromethane	O
and	O
carbon	O
tetrachloride	O
..	O
electron	O
ionization	O
and	O
thermospray	O
were	O
used	O
in	O
conjunction	O
with	O
tandem	O
mass	O
spectrometry	O
methods	O
to	O
identify	O
trichloromethyl	O
/	O
c	O
-	O
phenyl	O
-	O
n	O
-	O
tert	O
-	O
butyl	O
nitrone	O
(	O
pbn	O
)	O
spin	O
adducts	O
produced	O
in	O
rat	O
liver	O
microsomal	O
dispersions	O
that	O
had	O
been	O
treated	O
with	O
reduced	O
nicotinamide	B
adenine	O
dinucleotide	O
phosphate	O
(	O
nadph)-generating	O
system	O
and	O
brccl3	O
(	O
or	O
ccl4	O
)	O
.	O

therapeutic	O
effects	O
of	O
glucose	O
infusion	O
on	O
monochloroacetic	B
acid	I
exposure	O
in	O
rats	O
..	O
the	O
effects	O
of	O
glucose	O
infusion	O
on	O
monochloroacetate	O
(	O
mca	O
)	O
exposure	O
were	O
examined	O
in	O
male	O
rats	O
with	O
a	O
view	O
toward	O
effective	O
clinical	O
treatment	O
for	O
mca	O
intoxication	O
.	O

rats	O
were	O
injected	O
with	O
80	O
mg	O
/	O
kg	O
sodium	B
monochloroacetate	O
(	O
smca	O
)	O
(	O
single	O
lethal	O
dose	O
)	O
and	O
then	O
infused	O
with	O
saline	O
(	O
control	O
group	O
)	O
or	O
5	O
%	O
or	O
10	O
%	O
glucose	O
solution	O
at	O
2	O
ml	O
/	O
hour	O
for	O
ten	O
hours	O
.	O

we	O
evaluated	O
the	O
influence	O
of	O
physicochemical	O
properties	O
of	O
four	O
thms	O
(	O
chloroform	O
,	O
bromodichloromethane	O
,	O
dibromochloromethane	B
,	O
and	O
bromoform	O
)	O
on	O
the	O
internal	O
dose	O
after	O
showering	O
.	O

thm	O
levels	O
were	O
significantly	O
correlated	O
between	O
different	O
matrices	O
(	O
e.g.	O
dibromochloromethane	B
levels	O
)	O
in	O
water	O
and	O
air	O
(	O
r=0.941	O
)	O
;	O
blood	O
and	O
water	O
(	O
r=0.845	O
)	O
;	O
and	O
blood	O
and	O
air	O
(	O
r=0.831	O
)	O
.	O

disposition	O
of	O
bromodichloromethane	B
in	O
humans	O
following	O
oral	O
and	O
dermal	O
exposure	O
..	O
exposure	O
to	O
bromodichloromethane	B
(	O
bdcm	O
)	O
,	O
one	O
of	O
the	O
most	O
prevalent	O
disinfection	O
byproducts	O
in	O
drinking	O
water	O
,	O
can	O
occur	O
via	O
ingestion	O
of	O
water	O
and	O
by	O
dermal	O
absorption	O
and	O
inhalation	O
during	O
activities	O
such	O
as	O
bathing	O
and	O
showering	O
.	O

validation	O
of	O
urinary	O
trichloroacetic	B
acid	I
as	O
a	O
biomarker	O
of	O
exposure	O
to	O
drinking	O
water	O
disinfection	O
by	O
-	O
products	O
..	O
disinfection	O
by	O
-	O
products	O
(	O
dbps	O
)	O
in	O
drinking	O
water	O
represent	O
a	O
public	O
health	O
issue	O
and	O
a	O
challenge	O
for	O
epidemiology	O
to	O
provide	O
evidence	O
towards	O
the	O
causation	O
of	O
various	O
hypothesized	O
health	O
effects	O
.	O

the	O
objective	O
of	O
this	O
study	O
was	O
to	O
validate	O
urinary	O
trichloroacetic	B
acid	I
(	O
tcaa	O
)	O
excretion	O
as	O
a	O
biomarker	O
of	O
exposure	O
to	O
dbps	O
in	O
an	O
experimental	O
exposure	O
cohort	O
.	O

this	O
suggests	O
both	O
an	O
effect	O
of	O
dba	O
exposure	O
on	O
mitochondrial	O
cholesterol	B
transport	O
by	O
steroidogenic	O
acute	O
regulatory	O
protein	O
(	O
star	O
)	O
and	O
a	O
possible	O
impact	O
on	O
the	O
receptor	O
or	O
postreceptor	O
events	O
triggered	O
by	O
hcg	O
.	O

resulting	O
breath	O
samples	O
collected	O
during	O
the	O
workout	O
demonstrated	O
a	O
rapid	O
uptake	O
of	O
two	O
thms	O
(	O
chloroform	O
and	O
bromodichloromethane	B
)	O
,	O
with	O
chloroform	O
concentrations	O
exceeding	O
the	O
natatorium	O
air	O
levels	O
within	O
8	O
min	O
after	O
the	O
exposure	O
began	O
.	O

bromodichloromethane	B
elimination	O
was	O
fitted	O
to	O
a	O
two	O
compartment	O
model	O
which	O
provided	O
evidence	O
of	O
a	O
small	O
,	O
but	O
measurable	O
,	O
body	O
burden	O
of	O
this	O
thm	O
resulting	O
from	O
vigorous	O
swim	O
training	O
.	O

serum	O
hormone	O
characterization	O
and	O
exogeneous	O
hormone	O
rescue	O
of	O
bromodichloromethane	O
-	O
induced	O
pregnancy	O
loss	O
in	O
the	O
f344	O
rat	O
..	O
previously	O
,	O
we	O
demonstrated	O
that	O
bromodichloromethane	B
(	O
bdcm	O
)	O
,	O
a	O
drinking	O
water	O
disinfection	O
by	O
-	O
product	O
,	O
causes	O
pregnancy	O
loss	O
in	O
f344	O
rats	O
when	O
given	O
on	O
gestational	O
days	O
(	O
gd	O
)	O
6	O
-	O
10	O
,	O
encompassing	O
the	O
luteinizing	O
hormone	O
(	O
lh)-dependent	O
period	O
of	O
pregnancy	O
(	O
gd	O
7	O
-	O
10	O
)	O
.	O

urinary	O
concentrations	O
of	O
trichloroacetic	B
acid	I
in	O
danish	O
workers	O
exposed	O
to	O
trichloroethylene	O
,	O
1947	O
-	O
1985	O
..	O
background	O
:	O
since	O
1947	O
,	O
the	O
national	O
labour	O
inspection	O
service	O
in	O
denmark	O
has	O
relied	O
upon	O
urinary	O
measurements	O
of	O
trichloroacetic	B
acid	I
(	O
tca	O
)	O
in	O
surveys	O
of	O
the	O
occupational	O
exposure	O
to	O
trichloroethylene	O
(	O
tce	O
)	O
.	O

part	O
iii	O
:	O
studies	O
on	O
two	O
new	O
antigens	O
from	O
the	O
tricholoracetic	O
acid	O
soluble	O
fraction	O
..	O
two	O
new	O
antigens	O
were	O
isolated	O
from	O
the	O
trichloroacetic	B
acid	I
soluble	O
fraction	O
of	O
human	O
seminal	O
plasma	O
:	O
a	O
polysaccharide	O
(	O
g-3	O
)	O
and	O
a	O
glycopeptide	O
(	O
g-4	O
)	O
.	O

fatal	O
systemic	O
poisoning	O
after	O
skin	O
exposure	O
to	O
monochloroacetic	B
acid	I
..	O
little	O
information	O
is	O
available	O
on	O
the	O
toxicity	O
of	O
monochloroacetic	B
acid	I
.	O

we	O
report	O
the	O
case	O
of	O
a	O
38	O
year	O
-	O
old	O
man	O
who	O
was	O
splashed	O
with	O
an	O
80	O
%	O
monochloroacetic	B
acid	I
solution	O
on	O
25	O
-	O
30	O
%	O
of	O
his	O
body	O
surface	O
.	O

the	O
4	O
h	O
post	O
exposure	O
plasma	O
monochloroacetic	B
acid	I
concentration	O
was	O
33	O
mg	O
/	O
l	O
confirming	O
skin	O
absorption	O
.	O

in	O
addition	O
to	O
its	O
corrosive	O
action	O
,	O
monochloroacetic	B
acid	I
probably	O
blocks	O
the	O
tricarboxylic	O
acid	O
cycle	O
(	O
kreb	O
's	O
cycle	O
)	O
and	O
may	O
also	O
react	O
with	O
sulfhydryl	O
groups	O
in	O
enzymes	O
,	O
causing	O
severe	O
tissue	O
damage	O
in	O
energy	O
-	O
rich	O
organs	O
.	O

this	O
contribution	O
to	O
internal	O
dosimetry	O
,	O
such	O
as	O
maximal	O
venous	O
blood	O
concentrations	O
(	O
cmax	O
)	O
and	O
the	O
area	O
under	O
the	O
venous	O
blood	O
concentration	O
time	O
curve	O
(	O
auc	O
)	O
,	O
decreases	O
markedly	O
(	O
e.g.	O
,	O
as	O
low	O
as	O
0.9	O
%	O
of	O
cmax	O
for	O
bromodichloromethane	B
)	O
.	O

although	O
there	O
are	O
biomarkers	O
of	O
dbps	O
,	O
mainly	O
for	O
chloroform	O
and	O
more	O
recently	O
for	O
the	O
other	O
volatile	O
trihalomethanes	O
(	O
thms	O
)	O
and	O
the	O
nonvolatile	O
haloacetic	O
acids	O
(	O
haas	O
)	O
such	O
as	O
trichloroacetic	B
acid	I
(	O
tcaa	O
)	O
and	O
dichloroacetic	B
acid	I
(	O
dcaa	O
)	O
,	O
they	O
have	O
not	O
been	O
used	O
in	O
epidemiological	O
studies	O
.	O

decreased	O
birth	O
weight	O
in	O
relation	O
to	O
maternal	O
urinary	O
trichloroacetic	B
acid	I
levels	O
..	O
background	O
:	O
the	O
effect	O
of	O
exposure	O
to	O
disinfection	O
by	O
-	O
products	O
(	O
dbps	O
)	O
during	O
pregnancy	O
on	O
newborn	O
's	O
birth	O
weight	O
has	O
been	O
commonly	O
described	O
in	O
animal	O
studies	O
.	O

hepatocarcinogenicity	O
in	O
the	O
male	O
b6c3f1	O
mouse	O
following	O
a	O
lifetime	O
exposure	O
to	O
dichloroacetic	B
acid	I
in	O
the	O
drinking	O
water	O
:	O
dose	O
-	O
response	O
determination	O
and	O
modes	O
of	O
action	O
..	O
male	O
b6c3f	O
,	O
mice	O
were	O
exposed	O
to	O
dichloroacetic	B
acid	I
(	O
dca	O
)	O
in	O
the	O
drinking	O
water	O
in	O
order	O
to	O
establish	O
a	O
dose	O
response	O
for	O
the	O
induction	O
of	O
hepatocellular	O
cancer	O
and	O
to	O
examine	O
several	O
modes	O
of	O
action	O
for	O
the	O
carcinogenic	O
process	O
.	O

because	O
bromine	O
is	O
a	O
better	O
leaving	O
group	O
than	O
chlorine	O
,	O
metabolism	O
of	O
bromodichloromethane	B
(	O
bdcm	O
)	O
should	O
produce	O
the	O
same	O
intermediates	O
as	O
would	O
be	O
formed	O
from	O
tcm	O
.	O

analysis	O
of	O
trichloroacetic	B
acid	I
in	O
the	O
urine	O
of	O
workers	O
occupationally	O
exposed	O
to	O
trichloroethylene	O
by	O
capillary	O
gas	O
chromatography	O
..	O
a	O
gas	O
chromatographic	O
procedure	O
is	O
described	O
for	O
the	O
determination	O
of	O
trichloroacetic	B
acid	I
in	O
urine	O
,	O
the	O
major	O
metabolite	O
of	O
trichloroethylene	O
exposure	O
.	O

trichloroacetic	B
acid	I
was	O
derivatised	O
to	O
its	O
methyl	O
ester	O
with	O
bf3	O
/	O
methanol	O
reagent	O
and	O
then	O
extracted	O
into	O
toluene	O
and	O
analysed	O
by	O
capillary	O
gas	O
chromatography	O
using	O
electron	O
-	O
capture	O
detection	O
.	O

the	O
response	O
was	O
linear	O
in	O
the	O
range	O
0.4	O
-	O
100	O
mg	O
/	O
l	O
of	O
trichloroacetic	B
acid	I
in	O
urine	O
and	O
showed	O
a	O
relative	O
recovery	O
of	O
99.6	O
%	O
.	O

systemic	O
effects	O
and	O
skin	O
injury	O
after	O
experimental	O
dermal	O
exposure	O
to	O
monochloroacetic	B
acid	I
..	O

there	O
have	O
been	O
many	O
fatal	O
occupational	O
accidents	O
of	O
skin	O
exposure	O
to	O
monochloroacetic	B
acid	I
(	O
mca	O
)	O
.	O

oral	O
administration	O
of	O
potassium	B
bromate	O
,	O
a	O
major	O
water	O
disinfection	O
by	O
-	O
product	O
,	O
induces	O
oxidative	O
stress	O
and	O
impairs	O
the	O
antioxidant	O
power	O
of	O
rat	O
blood	O
..	O
potassium	B
bromate	O
(	O
kbro(3	O
)	O
)	O
is	O
a	O
widely	O
used	O
food	O
additive	O
,	O
a	O
water	O
disinfection	O
by	O
-	O
product	O
and	O
a	O
known	O
nephrotoxic	O
agent	O
.	O

nitric	O
oxide	O
levels	O
were	O
enhanced	O
while	O
vitamin	B
c	I
concentration	O
decreased	O
in	O
kbro(3	O
)	O
treated	O
animals	O
.	O

simple	O
and	O
sensitive	O
quantification	O
of	O
bioactive	O
peptides	O
in	O
biological	O
matrices	O
using	O
liquid	O
chromatography	O
/	O
selected	O
reaction	O
monitoring	O
mass	O
spectrometry	O
coupled	O
with	O
trichloroacetic	B
acid	I
clean	O
-	O
up	O
..	O
a	O
simple	O
and	O
sensitive	O
liquid	O
chromatography	O
/	O
electrospray	O
ionization	O
tandem	O
mass	O
spectrometric	O
(	O
lc	O
/	O
esi	O
-	O
ms	O
/	O
ms	O
)	O
method	O
has	O
been	O
developed	O
for	O
the	O
quantification	O
of	O
bioactive	O
peptides	O
in	O
biological	O
fluids	O
.	O

the	O
method	O
employs	O
protein	O
precipitation	O
with	O
4	O
%	O
trichloroacetic	B
acid	I
(	O
tca	O
)	O
and	O
selected	O
reaction	O
monitoring	O
(	O
srm	O
)	O
using	O
an	O
immonium	O
ion	O
as	O
the	O
product	O
ion	O
.	O

urinary	O
levels	O
of	O
trichloroacetic	B
acid	I
,	O
a	O
disinfection	O
by	O
-	O
product	O
in	O
chlorinated	O
drinking	O
water	O
,	O
in	O
a	O
human	O
reference	O
population	O
..	O
trichloroacetic	B
acid	I
(	O
tcaa	O
)	O
,	O
a	O
known	O
mouse	O
liver	O
carcinogen	O
and	O
a	O
possible	O
human	O
carcinogen	O
,	O
is	O
found	O
in	O
chlorinated	O
drinking	O
water	O
.	O

trichloroacetic	B
acid	I
in	O
urine	O
as	O
biological	O
exposure	O
equivalent	O
for	O
low	O
exposure	O
concentrations	O
of	O
trichloroethene	O
..	O
a	O
urinary	O
trichloroacetic	B
acid	I
(	O
tca	O
)	O
concentration	O
of	O
100	O
 	O
mg	O
/	O
l	O
at	O
the	O
end	O
of	O
the	O
last	O
work	O
shift	O
(	O
8	O
 	O
h	O
/	O
day	O
,	O
5	O
 	O
days	O
/	O
week	O
)	O
of	O
the	O
week	O
has	O
been	O
established	O
in	O
workers	O
as	O
exposure	O
equivalent	O
for	O
the	O
carcinogenic	O
substance	O
trichloroethene	O
(	O
eka	O
for	O
tri	O
)	O
at	O
an	O
exposure	O
concentration	O
of	O
50	O
 	O
ppm	O
tri	O
.	O

automated	O
trichloroacetic	B
acid	I
precipitation	O
method	O
for	O
urine	O
total	O
protein	O
..	O
urine	O
total	O
protein	O
determination	O
by	O
a	O
trichloroacetic	B
acid	I
(	O
tca	O
)	O
precipitation	O
method	O
was	O
automated	O
on	O
a	O
cobas	O
bio	O
centrifugal	O
analyser	O
.	O

